Target Name: MAGEH1
NCBI ID: G28986
Other Name(s): MAGE family member H1 | Restin | MAGEH | melanoma antigen family H, 1 | MAGE-H1 antigen | apoptosis-related protein 1 | MAGH1_HUMAN | Melanoma antigen, family H, 1 protein | APR1 | APR-1 | Apoptosis-related protein 1 | Melanoma-associated antigen H1 | melanoma antigen family H1 | restin

MAGEH1: A Protein Implicated in Disease

MAGEH1, also known as MAGE-A1, is a protein that belongs to the MAGE family of proteins. This family of proteins plays a crucial role in the immune response and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

One of the main functions of MAGEH1 is its role in the development and regulation of inflammation. MAGEH1 has been shown to be involved in the regulation of immune cell function and in the development of autoimmune diseases.

In addition to its role in inflammation, MAGEH1 has also been shown to be involved in the regulation of cell death and has been linked to a number of diseases, including cancer.

MAGEH1 has also been shown to be involved in the regulation of cell adhesion and has been implicated in the development of diseases that are characterized by the disruption of cell adhesion, such as cancer.

MAGEH1 has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival and is a key factor in the development and progression of many diseases.

MAGEH1 has also been shown to be involved in the regulation of cell cycle progression and has been implicated in the development of many types of cancer.

In conclusion, MAGEH1 is a protein that has been shown to be involved in a number of important functions in both normal and disease. As a drug target or biomarker, MAGEH1 has the potential to be a valuable tool for the development of new treatments for a wide range of diseases.

Protein Name: MAGE Family Member H1

More Common Targets

MAGEL2 | MAGI1 | MAGI1-AS1 | MAGI1-IT1 | MAGI2 | MAGI2-AS3 | MAGI3 | MAGIX | MAGOH | MAGOH-DT | MAGOHB | MAGT1 | MAIP1 | MAJIN | Major histocompatibility complex (MHC) antigen | Major Histocompatibility Complex Class I | Major histocompatibility complex class II antigens | MAK | MAK16 | MAL | MAL2 | MALAT1 | Malate dehydrogenase | MALL | MALLP2 | MALRD1 | MALSU1 | MALT1 | MAMDC2 | MAMDC2-AS1 | MAMDC4 | MAML1 | MAML2 | MAML3 | MAMLD1 | MAMSTR | MAN1A1 | MAN1A2 | MAN1B1 | MAN1B1-DT | MAN1C1 | MAN2A1 | MAN2A2 | MAN2B1 | MAN2B2 | MAN2C1 | MANBA | MANBAL | MANCR | MANEA | MANEA-DT | MANEAL | MANF | MANSC1 | MANSC4 | MAOA | MAOB | MAP10 | MAP1A | MAP1B | MAP1LC3A | MAP1LC3B | MAP1LC3B2 | MAP1LC3BP1 | MAP1LC3C | MAP1S | MAP2 | MAP2K1 | MAP2K1P1 | MAP2K2 | MAP2K3 | MAP2K4 | MAP2K4P1 | MAP2K5 | MAP2K6 | MAP2K7 | MAP3K1 | MAP3K10 | MAP3K11 | MAP3K12 | MAP3K13 | MAP3K14 | MAP3K14-AS1 | MAP3K15 | MAP3K19 | MAP3K2 | MAP3K2-DT | MAP3K20 | MAP3K20-AS1 | MAP3K21 | MAP3K3 | MAP3K4 | MAP3K5 | MAP3K5-AS2 | MAP3K6 | MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT